Anticonvulsant Drug Development (ADD) Program Information
Contact top employees from
Anticonvulsant Drug Development (ADD)...
Summary
Anticonvulsant Drug Development (ADD) Program has been in the industry for 51 years. The company currently specializes in the Research area. Its headquarters is located at US. The estimated number of employees - 4. To connect with Anticonvulsant Drug Development (ADD) Program employee register on SignalHire.
Organization Website | pharmacy.utah.edu |
Industries | |
Headquarters Location | 30 S 2000 E, Salt Lake City, Utah, 84112 US |
Employees Size | 10-50 employees |
Specialties | Epilepsy, neuroscience |
Founded | 1975 |
Estimated Website Traffic
The chart shows a decline in traffic to the utah.edu website. In November, traffic decreased to 35202210, compared to 35987255 in the previous month. The highest traffic in 2025 was recorded in September, reaching 36097616 visits.
Employees Turnover 4 quarter 2025
Length of Employment
Employee tenure at Anticonvulsant Drug Development (ADD) Program shows a diverse range of experience levels:
22% for 1–2 years22% for 3–4 years22% for 5–7 years11% for 8–10 years22% have over 11 years of service at Anticonvulsant Drug Development (ADD) ProgramContact top employees from
Anticonvulsant Drug Development (ADD)...
Christine Ligouri
Senior Research Analyst
Vanja Panic
Assistant Director (Operations)
Sharon Edwards
Senior Research Analyst
Ania Lobsinger
Undergraduate Research Assistant
Janint Camacho
Undergraduate Researcher
Similar Companies
FAQ
Anticonvulsant Drug Development (ADD) Program operates in the R&D industries. More details can be found on the official website: pharmacy.utah.edu.
The headquarters of Anticonvulsant Drug Development (ADD) Program are located in Salt Lake City, United States.
Anticonvulsant Drug Development (ADD) Program currently employs 10-50 people.
